The study failed to meet statistical significance for the primary endpoint, however, it did show a number of […]

The move follows a portfolio review by the French drug giant

The new condition is called Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS)

It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said

The research also suggests that coronavirus was more infectious than previously estimated

Updated Date: Mon, 01 Jun 2020 00:00:00 EDT

Updated Date: Mon, 01 Jun 2020 00:00:00 EDT

Updated Date: Mon, 01 Jun 2020 00:00:00 EDT

Updated Date: Mon, 01 Jun 2020 00:00:00 EDT

Updated Date: Mon, 01 Jun 2020 00:00:00 EDT